LFMD LifeMD, Inc.

Overview and Growth

LifeMD, Inc. generated $194.06M of revenue in fiscal 2025, with net income of $14.35M and an operating cash inflow of $8.28M. Revenue of $194.06M sets the scale for evaluating how effectively sales translated into profit and cash during the year. The top line expanded 25.3% from $154.82M in fiscal 2024, increasing the company’s operating scale. The company reported diluted EPS of $0.25, adding a shareholder-level measure to the absolute income figures considered below. At period end, total assets were $70.41M, framing the scale of the company’s operating and financing commitments. Asset turnover was 2.76x, relating the company’s annual revenue directly to the total assets reported at the period end.

Profitability

Gross profit was $166.34M, representing the portion of revenue remaining after the reported cost of revenue and before operating expenses. The gross-profit relationship equaled 85.7% of revenue, quantifying the portion retained before operating expenses were recognized. The company recorded an operating loss of $7.67M after the reported operating expense base. The operating loss equaled 4.0% of revenue, showing the scale of the operating deficit relative to sales. After all reported below-operating-line items, the company recorded net income of $14.35M for the fiscal year. Net margin was 7.4%, meaning that this portion of revenue remained as net income after all recognized expenses. The company reported a pretax loss of $10.19M, before the effect of income taxes. The pretax loss equaled 5.2% of revenue, measuring the pre-tax deficit against sales. Income tax expense totaled $45.72K, providing the reported tax component that separates pretax and after-tax earnings. Return on period-end equity was 62.0%, relating annual net income to the equity capital on the balance sheet. Return on period-end assets was 20.4%, connecting net income with the company’s total asset base. The company moved from a $21.41M net loss in fiscal 2024 to net income of $14.35M.

Liquidity and Capital Structure

At period end, the $70.41M asset base was financed through $47.25M of liabilities and $23.16M of equity. The near-term balance sheet paired $51.83M of current assets with $41.57M of current liabilities at the reporting date. Current assets covered current liabilities by 1.25x, leaving a positive buffer for near-term obligations. Cash and equivalents totaled $36.79M, identifying the most liquid reported component available within the broader current-asset balance. Cash and equivalents represented 88.5% of current liabilities, showing the portion of near-term obligations matched by reported cash alone. Equity equaled 32.9% of assets, showing the shareholder-capital layer within the company’s balance sheet. Liabilities represented 67.1% of total assets, quantifying the liability-funded share of the company’s resource base. Measured against total assets, cash and equivalents represented 52.2%, a balance-sheet composition measure rather than a liquidity forecast. The asset base changed 7.5% from $76.10M in fiscal 2024, leaving current total assets lower year over year. Cash and equivalents were 12.7% higher than fiscal 2024 cash of $32.65M, showing the year-over-year change in liquid resources.

Cash Flow and Earnings Quality

The company reported $8.28M of operating cash flow, a cash inflow that shows the cash generated by operations. The operating-cash-flow-to-net-income relationship was 0.58x, comparing cash generated by operations with the bottom-line earnings result. Capital expenditures used $1.87M, identifying the reported investment outflow deducted from operating cash flow in the free-cash-flow calculation. Relative to operating cash flow, capital expenditures measured 22.6%, connecting investment intensity with the company’s cash-generation base. Free cash flow came to $6.41M, leaving a positive amount after capital expenditures. Free cash flow represented 3.3% of revenue, linking post-investment cash generation with the company’s operating scale. The free-cash-flow-to-assets relationship was 9.1%, comparing post-investment cash with the balance-sheet asset base.

Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated Oct 21, 2026.